Health
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients – Healio
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant…
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant and hematopoietic-cell transplant recipients, according to a study published in Open Forum Infectious Diseases.
“Solid-organ and…
Continue Reading
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoRainbow Beach surfer’s untold 7/7 story
-
General17 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News16 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland